1. A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806). (March 2016) Authors: Lim, Sun Min; Cho, Byoung Chul; Kim, Sang-We; Kang, Seok Yun; Heo, Dae Seog; Kim, Heung Tae; Lee, Dae Ho; Kim, Dong-Wan; Jung, Minkyu; Choi, Jin-Hyuk; Shim, Hyo Sup; Choi, Jong Rak; Kim, Joo-Hang Journal: Lung cancer Issue: Volume 93(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806). (March 2016) Authors: Lim, Sun Min; Cho, Byoung Chul; Kim, Sang-We; Kang, Seok Yun; Heo, Dae Seog; Kim, Heung Tae; Lee, Dae Ho; Kim, Dong-Wan; Jung, Minkyu; Choi, Jin-Hyuk; Shim, Hyo Sup; Choi, Jong Rak; Kim, Joo-Hang Journal: Lung cancer Issue: Volume 93(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study. Issue 11 (November 2017) Authors: Ahn, Myung-Ju; Kim, Dong-Wan; Cho, Byoung Chul; Kim, Sang-We; Lee, Jong Seok; Ahn, Jin-Seok; Kim, Tae Min; Lin, Chia-Chi; Kim, Hye Ryun; John, Thomas; Kao, Steven; Goldman, Jonathan W; Su, Wu-Chou; Natale, Ronald; Rabbie, Sarit; Harrop, Bryony; Overend, Philip; Yang, Zhenfan; Yang, James Chih-Hsin Journal: Lancet Issue: Volume 5:Issue 11(2017) Page Start: 891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial. Issue 10 (1st April 2023) Authors: Herbst, Roy S.; Wu, Yi-Long; John, Thomas; Grohe, Christian; Majem, Margarita; Wang, Jie; Kato, Terufumi; Goldman, Jonathan W.; Laktionov, Konstantin; Kim, Sang-We; Yu, Chong-Jen; Vu, Huu Vinh; Lu, Shun; Lee, Kye Young; Mukhametshina, Guzel; Akewanlop, Charuwan; de Marinis, Filippo; Bonanno, Laur... Journal: Journal of clinical oncology Issue: Volume 41:Issue 10(2023) Page Start: 1830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Afatinib in heavily pretreated advanced NSCLC patients who progressed following prior gefitinib or erlotinib: Compassionate use program in Korea. (May 2018) Authors: Choi, Moon Ki; Ahn, Jin Seok; Kim, Young-Chul; Cho, Byoung Chul; Oh, In-Jae; Kim, Sang-We; Lee, Jong Seok; Kim, Joo-Hang; Ahn, Myung-Ju; Park, Keunchil Journal: Lung cancer Issue: Volume 119(2018) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial. Issue 5 (May 2016) Authors: Park, Keunchil; Tan, Eng-Huat; O'Byrne, Ken; Zhang, Li; Boyer, Michael; Mok, Tony; Hirsh, Vera; Yang, James Chih-Hsin; Lee, Ki Hyeong; Lu, Shun; Shi, Yuankai; Kim, Sang-We; Laskin, Janessa; Kim, Dong-Wan; Arvis, Catherine Dubos; Kölbeck, Karl; Laurie, Scott A; Tsai, Chun-Ming; Shahidi, Mehdi; Kim... Journal: Lancet oncology Issue: Volume 17:Issue 5(2016:May) Page Start: 577 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study. Issue 5 (May 2019) Authors: Zhou, Caicun; Kim, Sang-We; Reungwetwattana, Thanyanan; Zhou, Jianying; Zhang, Yiping; He, Jianxing; Yang, Jin-Ji; Cheng, Ying; Lee, Se-Hoon; Bu, Lilian; Xu, Tingting; Yang, Li; Wang, Chao; Liu, Ting; Morcos, Peter N; Lu, You; Zhang, Li Journal: Lancet Issue: Volume 7:Issue 5(2019) Page Start: 437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. ALK TKI therapy in patients with ALK-positive non-small cell lung cancer and brain metastases: A review of the literature and local experiences. (December 2022) Authors: Cicin, Irfan; Martin, Claudio; Haddad, Carolina Kawamura; Kim, Sang-We; Smolin, Alexey; Abdillah, Arif; Yang, Xue Journal: Critical reviews in oncology/hematology Issue: Volume 180(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study. Issue 30 (20th October 2021) Authors: Park, Keunchil; Haura, Eric B.; Leighl, Natasha B.; Mitchell, Paul; Shu, Catherine A.; Girard, Nicolas; Viteri, Santiago; Han, Ji-Youn; Kim, Sang-We; Lee, Chee Khoon; Sabari, Joshua K.; Spira, Alexander I.; Yang, Tsung-Ying; Kim, Dong-Wan; Lee, Ki Hyeong; Sanborn, Rachel E.; Trigo, José; Goto, Ko... Journal: Journal of clinical oncology Issue: Volume 39:Issue 30(2021) Page Start: 3391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Chemotherapy for advanced non-small-cell lung cancer patients with poor performance. Issue 5 (September 2010) Authors: Kim, Kyu-Pyo; Kim, Sang-We Journal: Expert review of clinical pharmacology Issue: Volume 3:Issue 5(2010) Page Start: 623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗